• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一份用于评估瘙痒的问卷:在尿毒症患者中的验证

A questionnaire for the assessment of pruritus: validation in uremic patients.

作者信息

Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M

机构信息

Department of Dermatology, Rabin Medical Center, Petah Tiqva, Israel.

出版信息

Acta Derm Venereol. 2001 May;81(2):108-11. doi: 10.1080/00015550152384236.

DOI:10.1080/00015550152384236
PMID:11501646
Abstract

A questionnaire was constructed for the evaluation and measurement of pruritus. The questionnaire, based on the short form of the McGill Pain Questionnaire, was tested in 145 patients suffering from uremic pruritus and currently undergoing hemodialysis treatment in 3 centers. The newly developed questionnaire proved to be reliable and provided valid data on the sensory, affective and overall intensity of uremic pruritus. The data suggest that uremic pruritus tends to be prolonged, frequently intense and a major source of distress to the patient. Dialysis was not found to influence the pruritus. The questionnaire may also be useful in pruritus secondary to other causes.

摘要

构建了一份用于评估和测量瘙痒的问卷。该问卷基于麦吉尔疼痛问卷简表,在3个中心对145名患有尿毒症瘙痒且正在接受血液透析治疗的患者进行了测试。新开发的问卷被证明是可靠的,并提供了关于尿毒症瘙痒的感觉、情感和总体强度的有效数据。数据表明,尿毒症瘙痒往往持续时间长,常常较为剧烈,是患者痛苦的主要来源。未发现透析会影响瘙痒。该问卷可能对其他原因引起的瘙痒也有用。

相似文献

1
A questionnaire for the assessment of pruritus: validation in uremic patients.一份用于评估瘙痒的问卷:在尿毒症患者中的验证
Acta Derm Venereol. 2001 May;81(2):108-11. doi: 10.1080/00015550152384236.
2
Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease.血液透析患者中尿毒症瘙痒的患病率及特征:尿毒症瘙痒仍是终末期肾病患者的一个主要问题。
J Am Acad Dermatol. 2003 Nov;49(5):842-6. doi: 10.1016/s0190-9622(03)02478-2.
3
Uremic pruritus in chronic hemodialysis patients.慢性血液透析患者的尿毒症瘙痒
J Nephrol. 2008 Mar-Apr;21(2):161-5.
4
Uremic pruritus and serum phosphorus level.尿毒症瘙痒与血清磷水平。
Acta Med Iran. 2013 Aug 7;51(7):477-81.
5
Clinical interpretation of the Uremic Pruritus in Dialysis Patients (UP-Dial) scale: a novel instrument for the assessment of uremic pruritus.透析患者瘙痒量表(UP-Dial)的临床解读:一种评估尿毒症瘙痒的新工具。
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1188-1194. doi: 10.1111/jdv.14609. Epub 2017 Oct 16.
6
Uremic pruritus. Clinical and experimental studies.尿毒症瘙痒症。临床与实验研究。
Acta Derm Venereol Suppl (Stockh). 1989;145:1-38.
7
An epidemiology study of patients with uremic pruritus.一项关于尿毒症瘙痒患者的流行病学研究。
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):672-8. doi: 10.1111/j.1468-3083.2006.01570.x.
8
Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients.两种透析后加巴喷丁给药方案治疗血液透析患者重度尿毒症瘙痒的随机试验
Intern Emerg Med. 2019 Nov;14(8):1341-1346. doi: 10.1007/s11739-019-02175-4. Epub 2019 Sep 7.
9
Uremic pruritus: a clinical study of maintenance hemodialysis patients.尿毒症瘙痒:维持性血液透析患者的临床研究
J Dermatol. 2002 Oct;29(10):621-7. doi: 10.1111/j.1346-8138.2002.tb00191.x.
10
Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.组胺和5-羟色胺与尿毒症瘙痒:昂丹司琼对持续性非卧床腹膜透析相关性瘙痒患者的影响
Nephron. 1998;78(4):395-402. doi: 10.1159/000044967.

引用本文的文献

1
Energy-adjusted dietary inflammatory index is associated with chronic kidney disease-associated pruritus in Hemodialysis patients: a cross-sectional study.能量调整饮食炎症指数与血液透析患者慢性肾脏病相关瘙痒症的关系:一项横断面研究
BMC Nephrol. 2025 Jul 1;26(1):324. doi: 10.1186/s12882-025-04211-2.
2
A Study on Scratching Behavior Characteristics in Patients With Various Types of Chronic Pruritus.各类慢性瘙痒患者搔抓行为特征的研究
Allergy Asthma Immunol Res. 2025 May;17(3):371-383. doi: 10.4168/aair.2025.17.3.371.
3
CKD-associated pruritus in haemodialysis: a road map for diagnosis and treatment.
血液透析中与慢性肾脏病相关的瘙痒:诊断与治疗路线图
Clin Kidney J. 2025 Apr 24;18(5):sfaf096. doi: 10.1093/ckj/sfaf096. eCollection 2025 May.
4
The association Malnutrition-Inflammation Score with chronic kidney disease-associated pruritus and quality of life in hemodialysis patients: a multicenter cross-sectional study.营养不良-炎症评分与血液透析患者慢性肾脏病相关性瘙痒及生活质量的关系:一项多中心横断面研究。
Sci Rep. 2024 Dec 30;14(1):31811. doi: 10.1038/s41598-024-83100-4.
5
The Pathogenesis of CKD-Associated Pruritus: A Theoretical Model and Relevance for Treatment.慢性肾脏病相关性瘙痒症的发病机制:理论模型与治疗相关性。
Kidney360. 2024 Nov 1;5(11):1727-1738. doi: 10.34067/KID.0000000573. Epub 2024 Sep 4.
6
Effect of Dill () Oil on Pruritus and Quality of Life of Hemodialysis Patients: A Randomized Double-Blind Three-Arm Controlled Trial.莳萝油对血液透析患者瘙痒及生活质量的影响:一项随机双盲三臂对照试验。
Evid Based Complement Alternat Med. 2024 Jan 12;2024:3077603. doi: 10.1155/2024/3077603. eCollection 2024.
7
The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis.慢性肾脏病相关瘙痒的负担:透析患者的混合方法分析
Kidney Med. 2023 Jul 1;5(9):100696. doi: 10.1016/j.xkme.2023.100696. eCollection 2023 Sep.
8
A phase IV, randomised, double-blind, controlled, parallel group trial to evaluate the effectiveness and safety of Balneum Plus versus emollient in the treatment of chronic kidney disease-associated pruritus in haemodialysis patients.一项IV期随机双盲对照平行组试验,旨在评估Balneum Plus与润肤剂治疗血液透析患者慢性肾脏病相关性瘙痒的有效性和安全性。
Clin Kidney J. 2023 Mar 29;16(8):1307-1315. doi: 10.1093/ckj/sfad066. eCollection 2023 Aug.
9
The impact of underlying diseases-related drugs on the chronic kidney disease-associated pruritus in hemodialysis patients.基础疾病相关药物对血液透析患者慢性肾脏病相关性瘙痒的影响。
J Res Med Sci. 2022 Nov 25;27:86. doi: 10.4103/jrms.jrms_633_21. eCollection 2022.
10
Validation of Relationship between Patients' Descriptions of Pruritus and Patient-burden of Chronic Pruritus using Structural Equation Modelling.采用结构方程模型验证患者瘙痒描述与慢性瘙痒患者负担之间的关系。
Acta Derm Venereol. 2022 Nov 24;102:adv00819. doi: 10.2340/actadv.v102.2527.